tiprankstipranks
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market
NEVI
Pascal Biosciences Inc
RESEARCH TOOLSreports

Pascal Biosciences Inc (NEVI) Ratios

5 Followers

Pascal Biosciences Inc Ratios

TSE:NEVI's free cash flow for Q4 2025 was C$-0.20. For the 2025 fiscal year, TSE:NEVI's free cash flow was decreased by C$ and operating cash flow was C$-0.76. See a summary of the company’s cash flow.
Ratios
TTM
Nov 25Feb 25Feb 24Nov 22
Liquidity Ratios
Current Ratio
 0.75 0.75 1.08 0.79 0.02
Quick Ratio
 0.45 0.45 0.51 0.57 0.02
Cash Ratio
 0.14 0.14 0.23 0.37 <0.01
Solvency Ratio
 -0.02 -0.02 -0.14 -0.26 -0.49
Operating Cash Flow Ratio
 0.08 0.08 -0.21 -0.34 -0.17
Short-Term Operating Cash Flow Coverage
 0.25 0.25 -0.42 -0.56 -0.66
Net Current Asset Value
C$ -189.00KC$ -189.00KC$ -192.75KC$ -237.43KC$ -944.11K
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.26 0.27 11.93
Debt-to-Equity Ratio
 0.25 0.25 0.43 0.50 -0.24
Debt-to-Capital Ratio
 0.20 0.20 0.30 0.33 -0.31
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.16 0.00 0.00
Financial Leverage Ratio
 1.77 1.77 1.66 1.81 -0.02
Debt Service Coverage Ratio
 -0.10 -0.11 -0.14 -0.40 -2.05
Interest Coverage Ratio
 -5.33 -5.38 -3.50 0.00 -142.75
Debt to Market Cap
 0.18 0.12 0.13 0.36 0.17
Interest Debt Per Share
 <0.01 <0.01 0.02 0.03 0.02
Net Debt to EBITDA
 -4.65 -4.35 -8.29 -0.97 -0.46
Profitability Margins
Gross Profit Margin
41.26%23.37%69.45%58.51%0.00%
EBIT Margin
-17.00%-17.13%-19.32%-56.36%0.00%
EBITDA Margin
-1.80%-1.93%-3.10%-40.44%0.00%
Operating Profit Margin
-16.97%-17.13%-14.20%-129.27%0.00%
Pretax Profit Margin
-16.22%-16.22%-23.39%-59.53%0.00%
Net Profit Margin
-16.22%-16.22%-23.39%-59.53%0.00%
Continuous Operations Profit Margin
-16.22%-16.22%-23.39%-59.53%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
95.59%94.71%164.65%46.05%86.24%
Return on Assets (ROA)
-16.04%-16.04%-17.78%-16.02%-2551.56%
Return on Equity (ROE)
-23.67%-28.39%-29.58%-29.05%50.87%
Return on Capital Employed (ROCE)
-29.70%-29.98%-15.01%-63.07%66.90%
Return on Invested Capital (ROIC)
-23.72%-23.94%-12.55%-42.15%91.63%
Return on Tangible Assets
-48.23%-48.23%-56.36%-44.35%-2551.56%
Earnings Yield
-19.82%-13.87%-9.01%-21.24%-36.64%
Efficiency Ratios
Receivables Turnover
 7.53 7.53 9.97 3.25 0.00
Payables Turnover
 3.75 4.89 1.66 0.86 0.00
Inventory Turnover
 4.45 5.81 1.43 1.12 0.00
Fixed Asset Turnover
 130.88 130.88 69.27 33.88 0.00
Asset Turnover
 0.99 0.99 0.76 0.27 0.00
Working Capital Turnover Ratio
 -15.92 -24.08 -16.38 -1.26 0.00
Cash Conversion Cycle
 33.09 36.68 72.19 14.56 0.00
Days of Sales Outstanding
 48.47 48.47 36.62 112.42 0.00
Days of Inventory Outstanding
 82.02 62.87 255.39 325.26 0.00
Days of Payables Outstanding
 97.40 74.66 219.82 423.12 0.00
Operating Cycle
 130.49 111.34 292.01 437.68 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 >-0.01 -0.02 -0.01
Free Cash Flow Per Share
 <0.01 <0.01 >-0.01 -0.02 -0.01
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.10 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 20.70K 0.00 -10.42 -74.93 0.00
Capital Expenditure Coverage Ratio
 20.70K 0.00 -10.42 -74.93 0.00
Operating Cash Flow Coverage Ratio
 0.25 0.25 -0.23 -0.56 -0.66
Operating Cash Flow to Sales Ratio
 0.04 0.04 -0.08 -0.57 0.00
Free Cash Flow Yield
4.47%3.13%-3.28%-20.75%-11.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.05 -7.21 -11.10 -4.71 -2.73
Price-to-Sales (P/S) Ratio
 0.82 1.17 2.60 2.80 0.00
Price-to-Book (P/B) Ratio
 1.43 2.05 3.28 1.37 -1.39
Price-to-Free Cash Flow (P/FCF) Ratio
 22.35 31.93 -30.47 -4.82 -8.88
Price-to-Operating Cash Flow Ratio
 22.35 31.93 -33.40 -4.88 -8.88
Price-to-Earnings Growth (PEG) Ratio
 -0.05 0.26 0.25 0.09 0.05
Price-to-Fair Value
 1.43 2.05 3.28 1.37 -1.39
Enterprise Value Multiple
 -50.13 -65.06 -92.01 -7.91 -3.26
Enterprise Value
 1.53M 2.13M 4.42M 2.15M 1.53M
EV to EBITDA
 -50.13 -65.06 -92.01 -7.91 -3.26
EV to Sales
 0.90 1.25 2.85 3.20 0.00
EV to Free Cash Flow
 24.64 34.22 -33.49 -5.50 -10.34
EV to Operating Cash Flow
 24.64 34.22 -36.71 -5.57 -10.34
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 -0.07
Shareholders’ Equity Per Share
 0.02 0.02 0.03 0.06 -0.07
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 <0.01
Revenue Per Share
 0.04 0.04 0.04 0.03 0.00
Net Income Per Share
 >-0.01 >-0.01 >-0.01 -0.02 -0.04
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.95 0.95 1.21 1.06 1.01
Research & Development to Revenue
 0.00 0.00 0.00 0.05 0.00
SG&A to Revenue
 0.48 0.41 0.63 1.41 0.00
Stock-Based Compensation to Revenue
 0.01 0.00 0.02 0.61 0.00
Income Quality
 -0.23 -0.23 0.33 0.96 0.31
Currency in CAD